Account Executive - MI Clarity - Maryland-The Capitol
Caris Life Sciences
August 20, 2026
Remote friendly (Maryland, United States)
United States
Sales
Position Summary
- Drive awareness, adoption, and utilization of MI Clarity, an AI-powered prognostic assay for early and late distant recurrence risk in postmenopausal HR+/HER2-, node-negative early-stage breast cancer.
- Partner with oncologists, breast surgeons, pathologists, nurse navigators, and healthcare systems to educate stakeholders, integrate the assay into clinical workflows, and increase appropriate utilization.
Job Responsibilities
- Educate providers on MI Clarity’s clinical utility and evidence.
- Present clinical/validation data; explain differentiation of AI-driven pathology vs traditional assays.
- Lead in-person/virtual programs and consultative discussions on risk stratification, treatment planning, extended endocrine therapy, and reducing over/undertreatment.
- Position MI Clarity as decision-support; address performance, patient selection, workflow integration, turnaround time, and clinical interpretation.
- Develop/execute territory and account plans; build KOL and stakeholder relationships.
- Support testing workflow implementation and operational integration.
- Analyze performance/usage data to identify growth opportunities.
- Maintain accurate CRM documentation and forecasting; collaborate cross-functionally.
Required Qualifications
- Bachelor’s degree (life sciences/healthcare preferred).
- 3+ years sales experience in oncology, diagnostics, molecular testing, pathology, medical device, or pharmaceutical sales.
- Strong breast cancer/oncology pathway knowledge; consultative selling.
- Ability to interpret/communicate clinical data; travel within territory.
Preferred Qualifications
- Oncology diagnostics/precision medicine sales; relationships in oncology/breast centers.
- Launch experience; pathology/digital pathology familiarity; prognostic/predictive assay knowledge.
- Provider engagement; workflow implementation; territory growth; CRM accuracy.
- Drive awareness, adoption, and utilization of MI Clarity, an AI-powered prognostic assay for early and late distant recurrence risk in postmenopausal HR+/HER2-, node-negative early-stage breast cancer.
- Partner with oncologists, breast surgeons, pathologists, nurse navigators, and healthcare systems to educate stakeholders, integrate the assay into clinical workflows, and increase appropriate utilization.
Job Responsibilities
- Educate providers on MI Clarity’s clinical utility and evidence.
- Present clinical/validation data; explain differentiation of AI-driven pathology vs traditional assays.
- Lead in-person/virtual programs and consultative discussions on risk stratification, treatment planning, extended endocrine therapy, and reducing over/undertreatment.
- Position MI Clarity as decision-support; address performance, patient selection, workflow integration, turnaround time, and clinical interpretation.
- Develop/execute territory and account plans; build KOL and stakeholder relationships.
- Support testing workflow implementation and operational integration.
- Analyze performance/usage data to identify growth opportunities.
- Maintain accurate CRM documentation and forecasting; collaborate cross-functionally.
Required Qualifications
- Bachelor’s degree (life sciences/healthcare preferred).
- 3+ years sales experience in oncology, diagnostics, molecular testing, pathology, medical device, or pharmaceutical sales.
- Strong breast cancer/oncology pathway knowledge; consultative selling.
- Ability to interpret/communicate clinical data; travel within territory.
Preferred Qualifications
- Oncology diagnostics/precision medicine sales; relationships in oncology/breast centers.
- Launch experience; pathology/digital pathology familiarity; prognostic/predictive assay knowledge.
- Provider engagement; workflow implementation; territory growth; CRM accuracy.